ATE207532T1 - Synthetische stoffe und zusammensetzungen mit erhöhten zellbindungsvermögen - Google Patents

Synthetische stoffe und zusammensetzungen mit erhöhten zellbindungsvermögen

Info

Publication number
ATE207532T1
ATE207532T1 AT93900817T AT93900817T ATE207532T1 AT E207532 T1 ATE207532 T1 AT E207532T1 AT 93900817 T AT93900817 T AT 93900817T AT 93900817 T AT93900817 T AT 93900817T AT E207532 T1 ATE207532 T1 AT E207532T1
Authority
AT
Austria
Prior art keywords
compositions
collagen
cell
binding capacity
increased cell
Prior art date
Application number
AT93900817T
Other languages
English (en)
Inventor
Rajendra S Bhatnagar
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE207532T1 publication Critical patent/ATE207532T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93900817T 1991-12-09 1992-12-03 Synthetische stoffe und zusammensetzungen mit erhöhten zellbindungsvermögen ATE207532T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/804,782 US5354736A (en) 1989-08-14 1991-12-09 Synthetic compounds and compositions with enhanced cell binding
PCT/US1992/010420 WO1993011781A1 (en) 1991-12-09 1992-12-03 Synthetic compounds and compositions with enhanced cell binding

Publications (1)

Publication Number Publication Date
ATE207532T1 true ATE207532T1 (de) 2001-11-15

Family

ID=25189820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900817T ATE207532T1 (de) 1991-12-09 1992-12-03 Synthetische stoffe und zusammensetzungen mit erhöhten zellbindungsvermögen

Country Status (8)

Country Link
US (1) US5354736A (de)
EP (1) EP0618802B1 (de)
JP (1) JPH07501553A (de)
AT (1) ATE207532T1 (de)
CA (1) CA2124583C (de)
DE (1) DE69232153T2 (de)
ES (1) ES2169038T3 (de)
WO (1) WO1993011781A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674848A (en) * 1989-08-14 1997-10-07 The Regents Of The University Of California Bioreactor compositions with enhanced cell binding
US5635482A (en) 1989-08-14 1997-06-03 The Regents Of The University Of California Synthetic compounds and compositions with enhanced cell binding
US20030077825A1 (en) * 1994-07-22 2003-04-24 Bhatnagar Rajendra S. Structures useful for bone engineering and methods
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US5795790A (en) * 1994-07-20 1998-08-18 Cytotherapeutics, Inc. Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
US6638912B2 (en) * 1995-05-01 2003-10-28 The Regents Of The University Of California Peptide compositions mimicking TGF-β activity
US5780436A (en) * 1995-05-01 1998-07-14 The Regents Of The University Of California Peptide compositions with growth factor-like activity
US5861032A (en) * 1996-01-31 1999-01-19 Surface Genesis, Inc. Medical device having a biocompatible coating and oxidation method of coupling therefor
JP2000508922A (ja) 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
US5914121A (en) * 1997-02-12 1999-06-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Formation of human bone in vivo using ceramic powder and human marrow stromal fibroblasts
WO1998052620A2 (en) * 1997-05-16 1998-11-26 Novartis Ag Collagen-like polymers with cell binding activity
GB9714276D0 (en) 1997-07-08 1997-09-10 Univ Dundee Peptides and related compounds
ATE224213T1 (de) 1997-10-21 2002-10-15 Augmentec Ag Implantat aus resorbierbaren phosphatglas
US6224630B1 (en) 1998-05-29 2001-05-01 Advanced Bio Surfaces, Inc. Implantable tissue repair device
US6592625B2 (en) 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US7951201B2 (en) 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7615076B2 (en) 1999-10-20 2009-11-10 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7935147B2 (en) 1999-10-20 2011-05-03 Anulex Technologies, Inc. Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus
US7052516B2 (en) 1999-10-20 2006-05-30 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US7004970B2 (en) 1999-10-20 2006-02-28 Anulex Technologies, Inc. Methods and devices for spinal disc annulus reconstruction and repair
US8632590B2 (en) 1999-10-20 2014-01-21 Anulex Technologies, Inc. Apparatus and methods for the treatment of the intervertebral disc
US8128698B2 (en) 1999-10-20 2012-03-06 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6805695B2 (en) 2000-04-04 2004-10-19 Spinalabs, Llc Devices and methods for annular repair of intervertebral discs
US20040043398A1 (en) * 2002-04-15 2004-03-04 Demetrio Sanchez-Martinez Use of the multipin platform as anchor device
US8876532B2 (en) 2002-07-31 2014-11-04 Dentsply International Inc. Bone repair putty
US20050063937A1 (en) * 2003-09-16 2005-03-24 Cheng Li Multiple-arm peptide compounds, methods of manufacture and use in therapy
US9763977B2 (en) 2003-09-16 2017-09-19 Incube Labs, Llc In vitro bio-reactor circuit
US8329202B2 (en) * 2004-11-12 2012-12-11 Depuy Products, Inc. System and method for attaching soft tissue to an implant
US20060293228A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Therapeutic compositions and methods using transforming growth factor-beta mimics
US20060293227A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Cosmetic compositions and methods using transforming growth factor-beta mimics
US8048443B2 (en) * 2005-12-16 2011-11-01 Cerapedics, Inc. Pliable medical device and method of use
US20070269518A1 (en) * 2005-12-28 2007-11-22 Walline Katherine S Light-curable bone growth material for treating dental bone defects
US7807624B2 (en) * 2006-01-11 2010-10-05 Affinergy, Inc. Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
US8163022B2 (en) 2008-10-14 2012-04-24 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US8652153B2 (en) 2010-01-11 2014-02-18 Anulex Technologies, Inc. Intervertebral disc annulus repair system and bone anchor delivery tool
WO2014117107A1 (en) 2013-01-28 2014-07-31 Cartiva, Inc. Systems and methods for orthopedic repair
US9737294B2 (en) 2013-01-28 2017-08-22 Cartiva, Inc. Method and system for orthopedic repair
EP3197474B1 (de) 2014-09-26 2023-06-07 Rajendra Sahai Bhatnagar Inhibitoren der nf-kappa-b-aktivität zur behandlung von krankheiten und leiden
US11235086B2 (en) 2018-02-22 2022-02-01 Cerapedics, Inc. Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth
EP3530294A1 (de) 2018-02-22 2019-08-28 DSM IP Assets B.V. Verfahren zur beschichtung von anorganischen partikeln mit einem peptid oder protein zur verbesserung der zellulären aktivität im zusammenhang mit dem knochenwachstum
CN114306731B (zh) * 2021-12-28 2022-10-14 中国科学院上海硅酸盐研究所 多细胞打印神经化骨再生的活性支架及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060081A (en) * 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US4992226A (en) * 1985-03-28 1991-02-12 Collagen Corporation Method of making molds with xenogeneic collagen/mineral preparations for bone repair
US5034352A (en) * 1985-06-25 1991-07-23 Lifecore Biomedical, Inc. Calcium phosphate materials
US4994081A (en) * 1986-10-16 1991-02-19 Cbs Lens Method for locating on a cornea an artificial lens fabricated from a collagen-hydrogel for promoting epithelial cell growth
US5007934A (en) * 1987-07-20 1991-04-16 Regen Corporation Prosthetic meniscus
WO1991002537A1 (en) * 1989-08-14 1991-03-07 The Regents Of The University Of California Synthetic peptides that enhance cell binding

Also Published As

Publication number Publication date
JPH07501553A (ja) 1995-02-16
DE69232153T2 (de) 2002-06-27
WO1993011781A1 (en) 1993-06-24
US5354736A (en) 1994-10-11
ES2169038T3 (es) 2002-07-01
EP0618802B1 (de) 2001-10-24
CA2124583A1 (en) 1993-06-24
CA2124583C (en) 2010-08-10
EP0618802A1 (de) 1994-10-12
EP0618802A4 (en) 1996-12-18
DE69232153D1 (de) 2001-11-29

Similar Documents

Publication Publication Date Title
DE69232153D1 (de) Synthetische stoffe und zusammensetzungen mit erhöhten zellbindungsvermögen
ATE275981T1 (de) Knochentransplantat-composite und -spacern
GB8819755D0 (en) Chemical compound
MX9203253A (es) Material substituto oseo.
DK686788A (da) Subtilisinanaloger
DE69131556D1 (de) Zusammensetzung zum verbinden und abdichten von geweben und verfahren zu ihrer verwendung
DE3675083D1 (de) Material zum ausfuellen von periodontalen knochendefekten.
BR9007643A (pt) Metodo para se conseguir a epitelizacao de lentes sinteticas
DE3863011D1 (de) Biomaterialien aus mischungen von kollagen mit chitosan und glycosaminoglykanen, verfahren zu ihrer herstellung und ihre verwendung in der humanmedizin.
DE69632313D1 (de) Desorbierbare extrazelluläre matrix für rekonstruktion eines knorpelgewebes
ATE268188T1 (de) Kit und zusammensetzung zur behandlung und wiederherstellung von knochen- oder knorpeldefekten oder verletzungen
CR5743A (es) Antitranspirante en barra con caracteristicas mejoradas
PT87721A (pt) Novel proteins with factor viii activity process for their preparation using generically engineered cells and pharmaceutical compositions containing them
DE69831964D1 (de) Zusammensetzung zur förderung des wachstums von duralem oder meningealem gewebe enthaltend kollagen
NZ333725A (en) Keratinocyte growth factor-2 (KGF-2) deletion mutants
NZ210194A (en) Pentapeptides with thymopoietin and splenin like activity
ATE252134T1 (de) Bioaktives verbundmaterial zum reparieren von hartem und weichem gewebe
DE69413023D1 (de) Verwendung von hydrogelen auf der basis von hyaluronsäure und/oder polydeoxyribonukleotiden als füllmaterial für prothesen und so erhaltene prothesen
DE69406662D1 (de) Einsätze zur verwendung bei der gewebekultur
ATE58638T1 (de) Zusammensetzung und methode zur wiederherstellung von knochen.
ATE237373T1 (de) Epithelzellen enthaltendes biomaterial und ihre verwendung als transplantat
PT1007559E (pt) Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso
ATE112966T1 (de) Zusammensgesetztes material für orthopädische zwecke.
DE69934399D1 (de) Komplex aus peptid und mhc-peptid auf oberfläche von phagen
Tuross et al. The proteins in the shell of Lingula

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification